|
|
|
Scientific Advisory Committee |
|
|
Emeritus Professor John Chalmers AC - (Chair)
John Chalmers, AC FAA MD PhD FRACP
A graduate of the University of Sydney, John Chalmers was Foundation Professor and Head of Medicine at Flinders Medical Centre in Adelaide from 1975 to1996 where he was also Dean, Associate Dean or Clinical Dean. He is now Senior Director at The George Institute for International Health in Sydney, Emeritus Professor of Medicine at the University of Sydney and the Flinders University of South Australia and Honorary Consultant Physician at the Royal Prince Alfred Hospital. John Chalmers has made major contributions to both basic and clinical research in hypertension, recognised through admission to the Australian Academy of Science in 1987, and many national and international awards, including most recently, the Lifetime Achievement Award of the European Society of Hypertension in 2008. John has served as Chairman or President of the National Health and Medical Research Council of Australia, the Australian Society for Medical Research, the High Blood Pressure Research Council of Australia, the Royal Australasian College of Physicians, the International Society of Hypertension, the Scientific Advisory Board of the World Heart Federation and the WHO Expert Committee on Hypertension. He was appointed a Companion in the Order of Australia (AC) in 1991 and awarded the Centenary Medal of Australia in 2003.
|
|
| |
|
Professor David Briggs
Professor Briggs an Adjunct Professor at the University of Western Sydney recently finish his role as the Director of the Office of Complementary Medicines in the Therapeutic Goods Administration in Canberra. Prior to this he was Professor and Head of the School of Nutrition and Public Health at Deakin University. Professor Briggs has a MSc from the University of Melbourne and a PhD from the School of Pharmacy, University of London. His particular interests have been in the chemistry of natural products and nutrition and he has published many scientific papers, articles and texts in these areas.
|
|
| |
|
Professor Stephen Clarke
Professor Clarke is a medical oncologist and pharmacologist with major clinical research interest in colorectal cancer. He is currently Professor and Head of the Academic Department of Medicine at the Concord Hospital Clinical School of the University of Sydney. Stephen completed an FRACP in Medical Oncology at Royal North Shore Hospital in Sydney and then a PhD from the University of London at the Institute of Cancer Research/Royal Marsden Cancer Hospital in London. He returned from the UK in 1994 and joined the Sydney Cancer Centre in 1995.
|
 |
| |
|
Professor Marc Cohen
Professor Cohen is currently the Foundation Professor of Complementary Medicine at RMIT University, and President of the Australasian Integrative Medicine Association. He has a medical degree along with degrees in physiology and psychological medicine and PhDs in both Chinese medicine and biomedical engineering. Prof Cohen plays an active role in the teaching and research of complementary medicine with involvement in many clinical trials and basic science research projects. He is an Expert Advisor to the Australian Therapeutic Goods Administration's (TGA) Complementary Medicine Evaluation Committee (CMEC) and sits on the Editorial Board of four international journals. Prof Cohen has written, edited, and contributed to many highly regarded text books on holistic health and natural supplements and is currently working to develop a postgraduate Wellness Program within RMIT's School of Health Sciences.
|
 |
| |
|
Associate Professor David Colquhoun
Associate Professor Colquhoun is a Cardiologist in Private Practice in Brisbane. He has been extensively involved in research for the last 25 years, and has a private research group - Core Research. His group is involved in multi-centre international trials and investigator initiated trials in the area of lipids, nutrition, nutraceuticals and psychological aspects of heart disease, diabetes and obesity. Currently his research group is involved in 20 ongoing trials. He is Australian Co-ordinator of the SCOUT Trial: 13 Sites and over 900 patients in Australia and 9,000 patients worldwide. This trial will establish whether deliberate weight reduction reduced cardiovascular events. He was a member of the National Heart Foundation's (NHA) Nutrition and Metabolism Committee and NHF's Psycho-Social Working Group and chief author of NHFA Review of Fish and Omega 3 PUFA and position statement. He is the Chairman of the organising Committee of the NHFA 2nd Scientific Committee, Brisbane 2009 - the 50th Anniversary of NHFA.
|
 |
| |
|
Professor Richard Day
Professor Day is Clinical Pharmacology at UNSW and Director of Clinical Pharmacology & Toxicology at St Vincent's Hospital Sydney. He has a clinical practice in Clinical Pharmacology, Rheumatology and Pathology at St Vincent's Hospital. He was chairman of the Research Ethics Committee at St Vincent's Hospital (1990-1996) and a member of the UNSW Ethics Committee. He sat on the Training Awards (1994-9) and on the Research Ethics Subcommittee's (1995-97) of the NH&MRC. He was chairman of the review of the Clinical Trials Notification Scheme for the Federal Department of Health's Therapeutic Goods Association (1993) and has chaired a review of the Pharmaceutical Services Branch of the NSW Department of Health (1996/7). He was a Director of the MBF (1998-2003). Professor Day chaired the Pharmaceutical Health and Rational Use of Medicines Committee (PHARM), an expert committee advising the Federal Government on how to achieve ‘quality use of medicines' (QUM)(1999 -2008). He sat on the ‘Committee of Chairs' along with the chairs of NPS, APAC and PBAC, which also advised the Federal Government and co-ordinated activities in this sector of QUM during this time. He was a Board member (1999 - 2000; 2001-2004; 2004 - 7) of the international Drug Information Association. He was chair of the St Vincent's Hospital Drug Committee (1994-2003), clinical director of the NSW Medicines Information Centre (MIC), director of the St Vincent's clinical trials centre, membership of Australian Drug Evaluation Committee (ADEC-1991-96), independent member of the Medicines Australia (MA) Code of Conduct Subcommittee and chairmanship of NSW Therapeutic Assessment Group (NSWTAG) (1992-1999). More recently he has co-chaired the Medication Safety Taskforce of the Australian Safety and Quality Council for the Federal government (2002-4) and was appointed chair of the NSW Medication Safety Committee in 2008.
|
 |
| |
|
Professor Stephen Leeder AO, MD, PhD, BSc (Med), FRACP, FAFPHM, FFPH(UK), FRACGP(Hon)
Professor Stephen Leeder AO, MD, PhD, BSc (Med), FRACP, FAFPHM, FFPH(UK), FRACGP(Hon) is a professor of public health and community medicine at the University of Sydney. He is Director of the Australian Health Policy Institute, a University establishment that provides a high-level capability for authoritative, independent, non-partisan analysis of major health policy questions which confront Australian and international health systems. The Institute is the Australasian base of the Oxford Health Alliance (OxHA). Professor Leeder is also co-director of the Menzies Centre for Health Policy, a joint enterprise with The Australian National University. A major theme of the Centre is the control of, and care for people with, serious and continuing illness including chronic obstructive pulmonary disease, chronic heart failure and complicated diabetes. Professor Leeder has a long history of involvement in public health research, educational development and policy. His research interests as a clinical epidemiologist have been mainly asthma and cardiovascular disease.
In 2003-04, Professor Leeder worked at Columbia University, New York, in the Earth Institute and Mailman School of Public Health, developing a substantial report, based on research data and scientific interpretation, of the economic consequences of cardiovascular disease (CVD) in developing economies. The report, A Race against Time: the challenge of cardiovascular disease in developing economies, concentrated upon the macroeconomic consequences of CVD.
|
 |
| |
|
Professor Stephen Myers
Professor Myers is currently Director of the Natural and Complementary Medicine Research Unit (NatMed-Research) within the Department of Natural and Complementary Medicine at Southern Cross University. He initially qualified as a naturopathic practitioner and later in western medicine, and has a PhD in clinical pharmacology. Professor Myers has been extensively involved with naturopathic education in Australia, and is actively engaged in research in herbal medicine, therapeutic foods and in public health issues in complementary medicine. Professor Myers is also an Expert Advisor to the TGA's CMEC, and has acted as consultant to industry, government and educational institutions. Professor Myers has published widely, and is a member of the editorial panel of several national and international journals on complementary medicine and nutrition. He is currently a senior editor of the American Naturopathic Foundations Project creating the definitive textbook on Naturopathic Medicine. In 2004 he was awarded the prestigious Lady Cilento Award by the Complementary Healthcare Council for a sustained contribution to the field.
|
 |
| |
|
Professor Basil Roufogalis
Professor Roufogalis is Executive Director of the Herbal Medicines Research and Education Centre at the University of Sydney. After obtaining his PhD in medicinal chemistry he was awarded the DSc in 1996 for work on the regulation of cellular function by calcium. Following 18 years in Canada, leading to appointment as Professor at the University of British Columbia, he returned to Australia as an NHMRC Senior Research Fellow and Professor of Pharmaceutical Chemistry at the Faculty of Pharmacy, University of Sydney. He established the Herbal Medicines Research and Education Centre in 1997. Professor Roufogalis has undertaken research and education activities in development and safety of new herbal medicines.
|
 |
| |
|
Emeritus Professor Anthony Smith
Anthony Smith was born and educated in UK. Medical degree and research doctorate from Oxford University. Fellow, of the Royal College of Physicians (London). Lecturer in Medicine, Lagos University, Nigeria 1963-1965. Senior Lecturer, Pharmacology and Therapeutics, University of Sheffield, UK 1965-1977. Foundation Professor of Clinical Pharmacology, University of Newcastle, NSW, Australia 1978-1997. Emeritus Professor, Clinical Pharmacology, University of Newcastle, 1997 - present Member, WHO expert panel on drug policy and management. (1994-present) Chair, Australian Complementary Medicines Evaluation Committee (TGA)-1999-present. Consultant for various organisations (WHO, AusAID, HIC-World Bank). Over thirty consultancies in 15 (mostly) developing countries - since 1994. Most of these concerned medicinal policy and its implementation. Author of several book chapters and more than 160 articles in peer-reviewed journals.
|
 |
| |
|
Professor Con Stough
Professor Stough is Professor of Cognitive Neurosciences at the Brain Sciences Institute and Professor of Psychology at Swinburne University. The Brain Sciences Institute has 20 full time research staff and 40 PhD students and is a leading research and teaching institute in cognitive neuroscience. He has an extensive track record in research and consulting and has published more than 70 peer reviewed international expert papers in the area of psychological assessment, biological psychology and psychopharmacology. He has also attracted more than 3 million dollars in research grants over the last 6 years from National and International government and Industry sources. Professor Stough is on the advisory panel for the International Society for Intelligence Research and editorial board for the journal Intelligence and other international journals. He co-founded the Herbal and Nutraceutical Research Unit at Swinburne University and is a Director of the National Institute of Complementary Medicine (NICM) Collaborative Centre for Neurocognition and Herbal Medicines.
|
 |
| |
|
Associate Professor Luis Vitetta
Associate Professor Vitetta is currently Associate Professor and Principal Research Fellow, Unit of Health Integration, School of Medicine, University of Queensland, based at the Princess Alexandra Hospital in Brisbane. Previously he was Senior Research Fellow and Associate Professor at the Centre for Molecular Biology and Medicine at the Epworth Medical Centre in Melbourne and during the years 2000-2005 he was the Deputy Head and Director of Research of the Graduate School of Integrative Medicine at Swinburne University. He has served as a member of the Victorian Cancer Council's Epidemiology group, alternate Director of the Victorian Public Health Research and Education Council, and member of its research committee. He is currently a member of the executive board of the Australian Research Centre for Complementary and Alternative Medicine in Melbourne and Queensland's Pharmaceutical and Nutraceutical Interest Forum Group. He is an invited speaker at local and international conferences.
|
 |
| |
|
Professor Charlie Xue
Professor Charlie Xue is Head, Division of Chinese Medicine and Director, World Health Organization (WHO) Collaborating Centre for Traditional Medicine, RMIT University, Australia. He graduated from Guangzhou College of Traditional Chinese Medicine, China with a Bachelor of Medicine degree in 1987 and subsequently completed his PhD at RMIT University. Professor Xue has 21 years of teaching, research and clinical experience in China and Australia. Dr Xue is a member of the Expert Advisory Panel for Traditional Medicine of the WHO, and the Chinese Medicine Registration Board of Victoria. Dr Xue is a Co-Director of the National Collaborative Centre of Traditional Chinese Medicine which is one of the three such centres supported by the National Institute of Complementary Medicine in Australia. Professor Xue was the President of the First World Congress on Chinese Medicine (2003) and Chair of the International Symposium on Harmonisation of Traditional and Modern Medicine (2005) held in Melbourne, Australia.
|
 |
| |
|
International Advisors |
|
Professor Gerry Bodeker
Professor Gerry Bodeker, an Australian whose doctoral studies were at Harvard University, researches and advises on international public policy on traditional, complementary & alternative medicine. He has been Chair of the Commonwealth Working Group on Traditional & Complementary Medicine and done work on medicinal plant conservation for the World Bank, the Global Environment Facility and the UN Food & Agriculture Organization, for which he produced with colleagues a book on Medicinal Plants for Forest Conservation and Healthcare. He chaired the International Advisory Panel to the Government of Malaysia for the development of the herbal sector & is international editor of the Malaysian-based publication, the Journal of Tropical Medicinal Plants. He is advising the Malaysian Herbal Corporation on medicinal crops as components of Malaysia's new agricultural policy. Professor Bodeker has written extensively on traditional medicine and is co-founder of the WHO-affiliated Research Initiative on Traditional Antimalarial Methods (RITAM). He was Guest Editor on special issue on Traditional Medicine of the Royal Society of Medicine's journal Tropical Doctor. He is also founding editor of the Medline-listed Journal of Alternative & Complementary Medicine.
|
 |
| |
|
John (Jack) Killen Jr, MD
John (Jack) Killen Jr, MD is Deputy Director of NCCAM, performing a wide range of functions in support of the Director and the entire NCCAM organization. Dr. Killen's 26-year career at NIH has centered on the design, implementation, and management of multi-disciplinary clinical research programs and on the ethics of clinical research, beginning in 1980 when he joined the National Cancer Institute. In 1986, he left NIH to serve as Medical Director of the Whitman-Walker Clinic, a community-based HIV/AIDS services organization in Washington, D.C. He returned to the NIH in 1987 to join the Division of AIDS in the National Institute of Allergy and Infectious Diseases (NIAID) where he served as Deputy Director (1987 to 1993) and then as Director (1994 to 2001). During that time he played a leadership role in the creation and evolution of many of the major HIV/AIDS research programs of the NIH, and served on numerous domestic U.S. and international committees and advisory bodies relating to HIV/AIDS research. He later served as Associate Director for Research Ethics, NIAID, and Head of the International Research Section in the Department of Clinical Bioethics at the NIH's Warren Magnuson Clinical Center, focusing on ethical aspects of clinical research in the developing world. Immediately prior to joining NCCAM in 2003, Dr. Killen headed NIAIDS's Office of Biodefense Research. Dr. Killen holds a B.A. degree from Kenyon College (1971), and an M.D. degree from Tufts University (1975). He is board-certified in internal medicine and medical oncology, and has pursued additional training in end-of-life care and mind-body medicine. He has received multiple awards including the NIH Merit Award, the NIH Director's Award, the U.S. Public Health Service Special Recognition Award, the PHS Superior Service Award, and the Senior Executive Service Meritorious Executive Rank.
|
 |
Content Updated January 2009
|
|
Last Updated ( Monday, 25 January 2010 )
|
|
|
